PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (AMEX: LCI) today said it is encouraged by a legal development in Florida that could remove generic Levothyroxine Sodium from the state’s negative drug formulary.
PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (AMEX: LCI) today said it is encouraged by a legal development in Florida that could remove generic Levothyroxine Sodium from the state’s negative drug formulary.
